|
|
Volumn 1, Issue 1, 2012, Pages 6-8
|
|
California institute for regenerative medicine: Accelerating stem cell therapies in California and beyond
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHEMOKINE RECEPTOR CCR5;
MICRORNA;
B CELL LYMPHOMA;
CANCER STEM CELL;
CELL MEDIATED CYTOTOXICITY;
CHEMOKINE RECEPTOR CCR5 GENE;
EPIDERMOLYSIS BULLOSA DYSTROPHICA;
FERTILIZATION IN VITRO;
FUNDING;
GENETIC DISORDER;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PLURIPOTENT STEM CELL;
RECEPTOR GENE;
REGENERATIVE MEDICINE;
RETT SYNDROME;
SCHIZOPHRENIA;
SOLID TUMOR;
STEM CELL RESEARCH;
STEM CELL TRANSPLANTATION;
ANIMAL;
ARTICLE;
ECONOMICS;
FINANCIAL MANAGEMENT;
GOVERNMENT REGULATION;
HEALTH CARE POLICY;
LEGAL ASPECT;
MEDICAL RESEARCH;
ORGANIZATION;
ORGANIZATION AND MANAGEMENT;
UNITED STATES;
ACADEMIES AND INSTITUTES;
ANIMALS;
BIOMEDICAL RESEARCH;
CALIFORNIA;
GOVERNMENT REGULATION;
HEALTH POLICY;
HUMANS;
ORGANIZATIONAL OBJECTIVES;
REGENERATIVE MEDICINE;
RESEARCH SUPPORT AS TOPIC;
STEM CELL RESEARCH;
|
|
EID: 84872048762
PISSN: 21576564
EISSN: 21576580
Source Type: Journal
DOI: 10.5966/sctm.2011-0047 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
